Literature DB >> 27601583

Cytoplasmic ATXN7L3B Interferes with Nuclear Functions of the SAGA Deubiquitinase Module.

Wenqian Li1,2,3, Boyko S Atanassov1,2, Xianjiang Lan1,2,3, Ryan D Mohan4, Selene K Swanson5, Aimee T Farria1,2,3, Laurence Florens5, Michael P Washburn5,6, Jerry L Workman5, Sharon Y R Dent7,2.   

Abstract

The SAGA complex contains two enzymatic modules, which house histone acetyltransferase (HAT) and deubiquitinase (DUB) activities. USP22 is the catalytic subunit of the DUB module, but two adaptor proteins, ATXN7L3 and ENY2, are necessary for DUB activity toward histone H2Bub1 and other substrates. ATXN7L3B shares 74% identity with the N-terminal region of ATXN7L3, but the functions of ATXN7L3B are not known. Here we report that ATXN7L3B interacts with ENY2 but not other SAGA components. Even though ATXN7L3B localizes in the cytoplasm, ATXN7L3B overexpression increases H2Bub1 levels, while overexpression of ATXN7L3 decreases H2Bub1 levels. In vitro, ATXN7L3B competes with ATXN7L3 to bind ENY2, and in vivo, knockdown of ATXN7L3B leads to concomitant loss of ENY2. Unlike the ATXN7L3 DUB complex, a USP22-ATXN7L3B-ENY2 complex cannot deubiquitinate H2Bub1 efficiently in vitro Moreover, ATXN7L3B knockdown inhibits migration of breast cancer cells in vitro and limits expression of ER target genes. Collectively, our studies suggest that ATXN7L3B regulates H2Bub1 levels and SAGA DUB activity through competition for ENY2 binding.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27601583      PMCID: PMC5086525          DOI: 10.1128/MCB.00193-16

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  39 in total

1.  A TFTC/STAGA module mediates histone H2A and H2B deubiquitination, coactivates nuclear receptors, and counteracts heterochromatin silencing.

Authors:  Yue Zhao; Guillaume Lang; Saya Ito; Jacques Bonnet; Eric Metzger; Shun Sawatsubashi; Eriko Suzuki; Xavier Le Guezennec; Hendrik G Stunnenberg; Aleksey Krasnov; Sofia G Georgieva; Roland Schüle; Ken-Ichi Takeyama; Shigeaki Kato; László Tora; Didier Devys
Journal:  Mol Cell       Date:  2008-01-18       Impact factor: 17.970

2.  Ubiquitin-specific peptidase USP22 negatively regulates the STAT signaling pathway by deubiquitinating SIRT1.

Authors:  Ning Ao; Yanyan Liu; Hailiang Feng; Xiaocui Bian; Zhanwen Li; Bei Gu; Xiaomei Zhao; Yuqin Liu
Journal:  Cell Physiol Biochem       Date:  2014-06-23

3.  Telomeric protein Pin2/TRF1 induces mitotic entry and apoptosis in cells with short telomeres and is down-regulated in human breast tumors.

Authors:  S Kishi; G Wulf; M Nakamura; K P Lu
Journal:  Oncogene       Date:  2001-03-22       Impact factor: 9.867

4.  The tightly controlled deubiquitination activity of the human SAGA complex differentially modifies distinct gene regulatory elements.

Authors:  Guillaume Lang; Jacques Bonnet; David Umlauf; Krishanpal Karmodiya; Jennifer Koffler; Matthieu Stierle; Didier Devys; László Tora
Journal:  Mol Cell Biol       Date:  2011-07-11       Impact factor: 4.272

5.  Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer.

Authors:  Gennadi V Glinsky; Olga Berezovska; Anna B Glinskii
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

6.  USP22 regulates cell proliferation by deubiquitinating the transcriptional regulator FBP1.

Authors:  Boyko S Atanassov; Sharon Y R Dent
Journal:  EMBO Rep       Date:  2011-09-01       Impact factor: 8.807

7.  Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer.

Authors:  Chenfang Dong; Tingting Yuan; Yadi Wu; Yifan Wang; Teresa W M Fan; Sumitra Miriyala; Yiwei Lin; Jun Yao; Jian Shi; Tiebang Kang; Pawel Lorkiewicz; Daret St Clair; Mien-Chie Hung; B Mark Evers; Binhua P Zhou
Journal:  Cancer Cell       Date:  2013-02-28       Impact factor: 31.743

8.  USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma.

Authors:  Zhen Ning; Aman Wang; Jinxiao Liang; Yunpeng Xie; Jiwei Liu; Lu Feng; Qiu Yan; Zhongyu Wang
Journal:  Int J Oncol       Date:  2014-07-03       Impact factor: 5.650

9.  Subdivision of molecularly-classified groups by new gene signatures in breast cancer patients.

Authors:  Athanasios Armakolas; George P Stathopoulos; Adrianos Nezos; Apostolos Theos; Martha Stathaki; Michael Koutsilieris
Journal:  Oncol Rep       Date:  2012-09-05       Impact factor: 3.906

10.  Structural basis for assembly and activation of the heterotetrameric SAGA histone H2B deubiquitinase module.

Authors:  Alwin Köhler; Erik Zimmerman; Maren Schneider; Ed Hurt; Ning Zheng
Journal:  Cell       Date:  2010-04-29       Impact factor: 41.582

View more
  6 in total

1.  Pan-Cancer Methylated Dysregulation of Long Non-coding RNAs Reveals Epigenetic Biomarkers.

Authors:  Ning Zhao; Maozu Guo; Chunlong Zhang; Chunyu Wang; Kuanquan Wang
Journal:  Front Cell Dev Biol       Date:  2022-05-27

2.  Transcription and mRNA export machineries SAGA and TREX-2 maintain monoubiquitinated H2B balance required for DNA repair.

Authors:  Federica M Evangelista; Anne Maglott-Roth; Matthieu Stierle; Laurent Brino; Evi Soutoglou; László Tora
Journal:  J Cell Biol       Date:  2018-07-27       Impact factor: 10.539

3.  Characterization of a metazoan ADA acetyltransferase complex.

Authors:  Jelly H M Soffers; Xuanying Li; Anita Saraf; Christopher W Seidel; Laurence Florens; Michael P Washburn; Susan M Abmayr; Jerry L Workman
Journal:  Nucleic Acids Res       Date:  2019-04-23       Impact factor: 16.971

Review 4.  Dynamic modules of the coactivator SAGA in eukaryotic transcription.

Authors:  Youngseo Cheon; Harim Kim; Kyubin Park; Minhoo Kim; Daeyoup Lee
Journal:  Exp Mol Med       Date:  2020-07-03       Impact factor: 8.718

Review 5.  Sharing the SAGA.

Authors:  Dominique Helmlinger; László Tora
Journal:  Trends Biochem Sci       Date:  2017-09-27       Impact factor: 13.807

6.  Distinct effects on mRNA export factor GANP underlie neurological disease phenotypes and alter gene expression depending on intron content.

Authors:  Rosa Woldegebriel; Jouni Kvist; Noora Andersson; Katrin Õunap; Karit Reinson; Monica H Wojcik; Emilia K Bijlsma; Mariëtte J V Hoffer; Monique M Ryan; Zornitza Stark; Maie Walsh; Inge Cuppen; Marie-Jose H van den Boogaard; Diana Bharucha-Goebel; Sandra Donkervoort; Sara Winchester; Roberto Zori; Carsten G Bönnemann; Reza Maroofian; Emer O'Connor; Henry Houlden; Fang Zhao; Olli Carpén; Matthew White; Jemeen Sreedharan; Murray Stewart; Emil Ylikallio; Henna Tyynismaa
Journal:  Hum Mol Genet       Date:  2020-06-03       Impact factor: 6.150

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.